PitchBook: seed funding down with 900 deals in Q2 '17, after 1.1K in Q2 '16 and 1.5K in Q2 '15; investors blame over inflated valuations, tepid IPO market
Heather Somerville / Reuters :
Context & Ripple Effects
PitchBook's count of US seed deals falling to 900 in Q2 2017 — from 1.1K a year earlier and 1.5K in Q2 2015 — marks the second consecutive annual drop at the earliest stage of the venture pipeline, with investors pointing to inflated valuations and a tepid IPO market rather than a shortage of startups.
The pattern has since repeated on a larger scale each time valuations and exits cool: by mid-2022 US Series A and B funding posted its biggest early-stage decline since 2010 outside Q2 2020 ([[a:981033]]), and by Q2 2023 angel and seed deal counts were down roughly half year over year ([[a:841813]]) — making this 2017 report an early template for how seed activity leads the broader cycle.
First-order effects
- Founders raising their first institutional round face a visibly thinner check-writing market, and investors' stated rationale — over-inflated valuations — signals harder price negotiations at entry even before any macro turn.
- PitchBook's own dataset becomes the reference point VCs and LPs use to time the correction, since the two-year slide from 1.5K to 900 deals is measurable ahead of headline funding totals.
Second-order effects
- A tepid IPO market starves the exit end of the pipeline that recycles returns back into new funds, so the seed contraction pressures fund sizes and pace at every later stage — the same mechanism behind the 2022 Series A/B squeeze.
- With fewer seed deals clearing, competition concentrates among the startups that do get funded, pushing up round sizes for survivors while marginal companies delay or die quietly.
Third-order effects
- If the pattern holds across cycles, seed is confirmed as the most cyclical layer of venture capital — first to contract when valuations and exits wobble, and first to recover — while capital migrates toward fewer, larger rounds, a concentration visible again when five deals absorbed $32B of Q4 2024's $74.6B total ([[a:881444]]).
- Repeated valuation-driven pullbacks argue for structural discipline in early-stage pricing: entry valuations set in hot periods become the constraint that throttles deal flow two years later.
The trend: Seed deal counts function as a leading indicator of venture-cycle turns, contracting sharply whenever inflated valuations meet a weak IPO market — a rhythm PitchBook's data has now traced through multiple downturns.